|Will the success of mRNA vaccine development platforms for COVID-19 lead to new platforms for old vaccines?|
|There will be two main presentations as follows:|
The Immunological benefits of mRNA and potential applications
Regulatory approaches: Issues and challenges, and questions to be asked by regulators
Dr Martin Friede, WHO will chair the meeting.